IntegraGen's H1 Revenues Rise 18 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – French molecular diagnostics firm IntegraGen today said that revenues during the first half of 2013 increased 18 percent year over year.

The company, which develops MDx tests for autism and cancer, said that during the first six months of the year it posted revenues of €2.7 million ($3.7 million), compared to €$2.3 million a year ago. IntegraGen preannounced preliminary first-half 2013 revenues in July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.